Camille M. Fung
No Rating Available
(Learn About Our Rating System)

Camille M. Fung, MD

Languages spoken: English, Cantonese

Clinical Locations

Intermountain Medical Center

Murray
801-507-7000
Directions

Primary Children's Hospital

Newborn Intensive Care Unit
Salt Lake City
801-662-4100
Directions

University of Utah Hospital

Newborn Intensive Care Unit
Salt Lake City
801-581-2745
Directions

  • Camille Fung, M.D. is an Associate Professor in the Division of Neonatology, Department of Pediatrics, at the University of Utah School of Medicine. In addition to caring for sick newborns in 4 level III & IV NICUs in the Salt Lake valley as a neonatologist, she has a basic science research interest in determining the effects of intrauterine growth restriction (IUGR) on hippocampal neuronal development. This is important because IUGR infants are at increased risk for cognitive delays particularly affecting learning and memory, functions that are performed by the hippocampus, but the underlying mechanisms leading to such delays remain elusive. Due to inaccessibility of fetal/neonatal brain tissue, she uses a mouse model of IUGR that she developed and published in 2011, which mimics human hypertensive diseases of pregnancy, to study embryonic and postnatal hippocampal neurogenesis and synaptic development. Her most recent NIH R01 submission as the Principal Investigator scored 23% on the first submission and is awaiting funding decision as a New Investigator. In addition to understanding the effects of IUGR on the central nervous system (CNS), she has collaborations both within and outside of the University of Utah investigating the mechanisms of IUGR-induced retinopathy, necrotizing enterocolitis, and chronic lung disease/pulmonary hypertension. She has held multiple intramural and extramural grants including a NIH-sponsored co-Investigator R01 grant on the last IUGR complication. Relating to her basic science interest on CNS function, she has quality improvement and clinical research interests on improving the management of neonatal opioid withdrawal syndrome (NOWS) as well. The incidence of NOWS has skyrocketed across the U.S., attributed to prescription opioid use and misuse. She has worked closely with interdisciplinary teams both at Intermountain and University Healthcare systems to implement a care process model on NOWS management. Working with the Utah Department of Health, she has also disseminated this care process model to other healthcare systems across Utah such that a standardized practice exists for infants suffering from NOWS. She is currently a Principal Investigator and a co-Investigator on two NIH-funded clinical projects relating to NOWS through the Neonatal Research Network. Lastly, recognizing the concurrent use of other substances along with prescription opioids, Dr. Fung has been the course director who incepted a CME course since 2014 to address the opioid epidemic and has helped incept another course in 2020 to address the increasing use of cannabis in pregnant women. The first course satisfies the Utah Division of Professional Licensing (DOPL) requirement for opioid education mandated at each license cycle renewal and the second course satisfies the requirement to become a medical cannabis prescriber. These courses are accessible year round through the Substance Education Institute at substanceei.com and have educated thousands of learners over the last few years. She has additionally mentored pediatric residents, neonatal-perinatal fellows, undergraduate and graduate students both in basic science and in quality improvement projects.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Neonatal-Perinatal Medicine)

  • Camille Fung, M.D. is an Associate Professor in the Division of Neonatology, Department of Pediatrics, at the University of Utah School of Medicine. In addition to caring for sick newborns in 4 level III & IV NICUs in the Salt Lake valley as a neonatologist, she has a basic science research interest in determining the effects of intrauterine growth restriction (IUGR) on hippocampal neuronal development. This is important because IUGR infants are at increased risk for cognitive delays particularly affecting learning and memory, functions that are performed by the hippocampus, but the underlying mechanisms leading to such delays remain elusive. Due to inaccessibility of fetal/neonatal brain tissue, she uses a mouse model of IUGR that she developed and published in 2011, which mimics human hypertensive diseases of pregnancy, to study embryonic and postnatal hippocampal neurogenesis and synaptic development. Her most recent NIH R01 submission as the Principal Investigator scored 23% on the first submission and is awaiting funding decision as a New Investigator. In addition to understanding the effects of IUGR on the central nervous system (CNS), she has collaborations both within and outside of the University of Utah investigating the mechanisms of IUGR-induced retinopathy, necrotizing enterocolitis, and chronic lung disease/pulmonary hypertension. She has held multiple intramural and extramural grants including a NIH-sponsored co-Investigator R01 grant on the last IUGR complication. Relating to her basic science interest on CNS function, she has quality improvement and clinical research interests on improving the management of neonatal opioid withdrawal syndrome (NOWS) as well. The incidence of NOWS has skyrocketed across the U.S., attributed to prescription opioid use and misuse. She has worked closely with interdisciplinary teams both at Intermountain and University Healthcare systems to implement a care process model on NOWS management. Working with the Utah Department of Health, she has also disseminated this care process model to other healthcare systems across Utah such that a standardized practice exists for infants suffering from NOWS. She is currently a Principal Investigator and a co-Investigator on two NIH-funded clinical projects relating to NOWS through the Neonatal Research Network. Lastly, recognizing the concurrent use of other substances along with prescription opioids, Dr. Fung has been the course director who incepted a CME course since 2014 to address the opioid epidemic and has helped incept another course in 2020 to address the increasing use of cannabis in pregnant women. The first course satisfies the Utah Division of Professional Licensing (DOPL) requirement for opioid education mandated at each license cycle renewal and the second course satisfies the requirement to become a medical cannabis prescriber. These courses are accessible year round through the Substance Education Institute at substanceei.com and have educated thousands of learners over the last few years. She has additionally mentored pediatric residents, neonatal-perinatal fellows, undergraduate and graduate students both in basic science and in quality improvement projects.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Associate Professor (Clinical)
    Academic Divisions Neonatology
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Neonatal-Perinatal Medicine)

    Education history

    Fellowship Neonatology - UCLA Mattel Children's Hospital Clinical Fellow
    Research Fellow Developmental Biology - UCLA David Geffen School of Medicine Postdoctoral Research Fellow
    Residency Pediatrics - St. Christopher's Hosp. for Children Resident
    Internship Pediatrics - St. Christopher's Hospital for Children Intern
    Professional Medical Jefferson Medical College M.D.
    Graduate Training Graduate level Cell Physiology - University of San Francisco
    Undergraduate Biology major and Chemistry minor - Santa Clara University B.S.

    Selected Publications

    Journal Article

    1. Peters H, Dizon M, Dettman RW, Fung C, Chang J (). Metabolic reprogramming of oligodendrocytes in intrauterine growth restriction (revision requested). (Epub ahead of print) Developmental Neuroscience.
    2. Strnad FA, Brown AS, Wieben M, Cortes-Sanchez E, Williams ME, Fung CM (2024). Intrauterine Growth Restriction Alters Postnatal Hippocampal Dentate Gyrus Neuron and Microglia Morphology and Cytokine/Chemokine Milieu in Mice. Life (Basel), 14(12). (Read full article)
    3. Merhar SL, Hu Z, Devlin LA, Ounpraseuth ST, Simon AE, Smith PB, Walsh MC, Lee JY, Das A, Higgins RD, Crawford MM, Rice W, Paul DA, Maxwell JR, Telang SD, Fung CM, Wright T, Reynolds AM, Hahn D, Ross J, McAllister JM, Crowley M, Shaikh SK, Christ L, Brown J, Riccio J, Wong Ramsey K, Braswell EF, Tucker L, McAlmon K, Dummula K, Weiner J, White JR, Howell MP, Newman S, Snowden JN, Young LW, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network National Institutes of Health Environmental Influences on Child Health Outcomes Program Institutional Development Award States Pediatric Clinical Tri, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network National Institutes of Health Environmental Influences on Child Health Outcomes Program Institutional Development Award States Pediatric Clinical Trials Network (2025). Infant Feeding and Weight Trajectories in the Eat, Sleep, Console Trial: A Secondary Analysis of a Randomized Clinical Trial. JAMA Pediatr, 178(10), 976-984. (Read full article)
    4. Devlin LA, Hu Z, Merhar SL, Ounpraseuth ST, Simon AE, Lee JY, Das A, Crawford MM, Greenberg RG, Smith PB, Higgins RD, Walsh MC, Rice W, Paul DA, Maxwell JR, Fung CM, Wright T, Ross J, McAllister JM, Crowley M, Shaikh SK, Christ L, Brown J, Riccio J, Wong Ramsey K, Braswell EF, Tucker L, McAlmon K, Dummula K, Weiner J, White JR, Newman S, Snowden JN, Young LW, Eunice Kennedy Shriver NICHD Neonatal Research Network and NIH Environmental Influences on Child Health Outcomes ECHO Program Institutional Development Award States Pediatric Clinical Trials Network (2024). Influence of Eat, Sleep, and Console on Infants Pharmacologically Treated for Opioid Withdrawal: A Post Hoc Subgroup Analysis of the ESC-NOW Randomized Clinical Trial. JAMA Pediatr, 178(6), 525-532. (Read full article)
    5. Young LW, Ounpraseuth ST, Merhar SL, Hu Z, Simon AE, Bremer AA, Lee JY, Das A, Crawford MM, Greenberg RG, Smith PB, Poindexter BB, Higgins RD, Walsh MC, Rice W, Paul DA, Maxwell JR, Telang S, Fung CM, Wright T, Reynolds AM, Hahn DW, Ross J, McAllister JM, Crowley M, Shaikh SK, Puopolo KM, Christ L, Brown J, Riccio J, Wong Ramsey K, Akshatha, Braswell EF, Tucker L, McAlmon KR, Dummula K, Weiner J, White JR, Howell MP, Newman S, Snowden JN, Devlin LA, ACT NOW Collaborative (2023). Eat, Sleep, Console Approach or Usual Care for Neonatal Opioid Withdrawal. N Engl J Med. (Read full article)
    6. Nugent M, St Pierre M, Brown A, Nassar S, Parmar P, Kitase Y, Duck SA, Pinto C, Jantzie L, Fung C, Chavez-Valdez R (2023). Sexual dimorphism in the closure of the hippocampal postnatal critical period of synaptic plasticity after intrauterine growth restriction - link to oligodendrocyte and glial dysregulation. Dev Neurosci. (Read full article)
    7. Fung C, Cung T, Nelson C, Wang H, Bretz C, Ramshekar A, Brown A, Stoddard GJ, Hartnett ME (2023). Retinopathy of prematurity protection conferred by uteroplacental insufficiency through erythropoietin signaling in an experimental Murine Model. Pediatr Res. (Read full article)
    8. St Pierre M, Duck SA, Nazareth M, Fung C, Jantzie LL, Chavez-Valdez R (2023). Unbiased Quantitative Single-Cell Morphometric Analysis to Identify Microglia Reactivity in Developmental Brain Injury. Life (Basel), 13(4). (Read full article)
    9. Fung CM (2023). Effects of intrauterine growth restriction on embryonic hippocampal dentate gyrus neurogenesis and postnatal critical period of synaptic plasticity that govern learning and memory function. Front Neurosci, 17, 1092357. (Read full article)
    10. Chang J, Bashir M, Fung CM, Dettman R, Dizon M (2021). Intrauterine growth restriction followed by oxygen support uniquely interferes with genetic regulators of myelination. eNeuro, DOI: https://doi.org/10.1523/ENEURO.0263-20.2021.
    11. Bushati C, Chan B, Harmeson Owen A, Woodbury A, Yang M, Fung C, Lechtenberg E, Baserga M (2021). Implementing exclusive human milk diet to extremely low birth weight infants in a level III NICU. Nutr Clin Pract, doi: 10.1002/ncp.10625. Online ahead of print.
    12. Morris E, Bardsley T, Schulte K, Seidel J, Shakib JH, Buchi KF, Fung CM (2020). Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure. Am J Perinatol, 2020 Sep 6. doi: 10.1055/s-0040-1716490. Online ahead of print.
    13. Chang JL, Santiago C, Farrow K, Fung C, Brown AS, Dettman RW, Dizon MLV (2018). Intrauterine growth restriction and hyperoxia as a cause of white matter injury. Dev Neurosci, 40(4), 344-357.
    14. Gibbins KJ, Gibson-Corley KN, Brown AS, Wieben M, Law RC, Fung CM (2017). Effects of excess thromboxane A2 on placental development and nutrient transporters in a Mus musculus model of fetal growth restriction. Biol Reprod, 98(5), 695-704. (Read full article)
    15. Xie Y, Kaufmann D, Moulton M, Panahi S, Gaynes JA, Zhou D, Xue H, Fung C, Levine EM, Letsou A, Brennan KC, Dorsky RI (2017). Lef1-dependent hypothalamic neurogenesis inhibits anxiety. PLoS Biol, 15(8), e2002257.
    16. McKnight RA, Yost CC, Zinkhan EK, Fu Q, Callaway CW, Fung CM (2016). Intrauterine growth restriction inhibits expression of eukaryotic elongation factor 2 kinase, a regulator of protein translation. Physiol Genomics, 48(8), 616-25. (Read full article)
    17. Fung CM, White JR, Brown AS, Gong H, Weitkamp JH, Frey MR, McElroy SJ equal contribution (2016). Intrauterine growth restriction alters mouse intestinal architecture during development (PMID 26745886). PLoS One, 11(1), e0146542.
    18. McKnight RA, Yost CC, Yu X, Wiedmeier JE, Callaway CW, Brown AS, Fung CM (2015). Intrauterine growth restriction perturbs nucleosome depletion at a growth hormone responsive element in the mouse IGF1 gene (PMID 26487705). Physiol Genomics, Epub.
    19. Fung CM, Yang Y, Fu Q, Brown AS, Yu B, Callaway CW, Li J, Lane RH, McKnight RA equal contribution (2015). IUGR prevents IGF-1 upregulation in juvenile male mice by perturbing postnatal IGF-1 chromatin remodeling (PMID 25826117). Pediatr Res.
    20. Zinkhan EK, Lang BY, Yu B, Wang Y, Jiang C, Fitzhugh M, Dahl MJ, Campbell MS, Fung C, Malleske D, Albertine KH, Joss-Moore L, Lane RH (2014). Maternal tobacco smoke increased visceral adiposity and serum corticosterone levels in adult male rat offspring (PMID 24727947). Pediatr Res, 76(1), 17-23.
    21. Fung C, Ke X, Brown AS, Yu X, McKnight RA, Lane RH equal contribution (2012). Uteroplacental insufficiency alters rat hippocampal cellular phenotype in conjunction with ErbB receptor expression (PMID 22367251). Pediatr Res, 71(4-2), 1-8.
    22. Fung C, Brown A, Cox J, Callaway CW, McKnight RA, Lane RH (2011). Novel thromboxane A2 analog-induced IUGR mouse model (PMID 25141265). J Dev Orig Health Dis, 2(5), 291-301.
    23. Fung C, Shin D, Shin BC, Sankar R, Chaudhuri G, Devaskar SU (2010). Hypoxic-ischemic brain injury exacerbates neuronal apoptosis and precipitates spontaneous seizures in glucose transporter Isoform 3 heterozygous null mice (PMID 20857507). J Neurosci Res, 88(15), 3386-3398.
    24. Fung C, Zhao Y, Shin D, Shin BC, Thamotharan S, Sankar R, Ehninger D, Silva A, and Devaskar SU equal contribution (2010). Neuronal glucose transporter isoform 3 deficient mice demonstrate features of autism spectrum disorders (PMID 19506559). Mol Psychiatry, 15(3), 286-299.

    Review

    1. Fung C, McKnight RA, Lane RH (2013). Environmental influences on epigenetic gene regulation. [Review]. Neoreviews, 14(3), e121-e127.

    Book Chapter

    1. Fung C, Zinkhan E (2021). Short and long term implications of small for gestational age. In Blue N.R. and Silver R. (Eds.), Obstetrics and Gynecology Clinics (https://doi.org/10.1016/j.ogc.2021.02.004, pp. 311-323). Elsevier.
    2. Fung CM, Devaskar SU (2006). Nutrient Regulation In Brain Development: Glucose and Alternate Fuels. In Hay W (Ed.), Neonatal Nutrition and Metabolism (Second Edition). Cambridge University Press.

    Case Report

    1. Hooper SM, Fung CM, Torr C, Lawrence SM (2025). Case Report: Delayed Recurrence of Staphylococcal Scalded Skin Syndrome in an Extremely Low Birth Weight Infant. Frontiers in Pediatrics, section Neonatology, 13(1564633).
    2. Malone Jenkins S, Cipriano S, Fung C (2016). Rash under phototherapy in a two day old preterm male. Neoreviews.

    Video/Film/CD/Web/Podcast

    1. Fung C, Buchi KF (2020). Marijuana Use During Pregnancy and Breastfeeding [Web].
    2. Fung C (03/06/2018). Mitigating the Opioid Epidemic in Pregnant Women and Newborn Infants on a Shoestring Budget [Web]. Philadelphia: ReachMD. Available: https://reachmd.com/programs/lifelong-learning/mitigating-the-opioid-epidemic-in-pregnant-women-and-newborn-infants-on-a-shoestring-budget/10021/.
    3. Munson K (10/31/2017). A State of Addiction: Utah's Opioid Epidemic. A 13-part series on Utah Public Radio. Interview with Dr. Camille Fung [Podcast]. Logan: Utah State University. Available: https://www.upr.org/programs/state-addiction-utahs-opioid-epidemic.

  • News & Podcasts

    News